Artelo BiosciencesARTL
那斯達克 · USD
3.51
-0.17
(-4.62%)
收盤 10/06 03:57 (UTC+8)
盤後
3.50
3.50
(-0.28%)
10/06 03:57 (UTC+8)
Artelo BiosciencesARTL
3.51
-0.17
(-4.62%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 2,505 | 2,689 | 2,786 | 3,089 | 3,150 | - | 3,812 | 1,195 | 2,512 | 2,589 |
研發費用 | 876 | 773 | 893 | 1,275 | 1,871 | 1,384 | 2,476 | 325 | 1,685 | 1,507 |
推銷及管理費用 | 1,629 | 1,916 | 1,893 | 1,814 | 1,279 | 995 | 1,336 | 870 | 827 | 1,082 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -2,505 | -2,689 | -2,786 | -3,089 | -3,150 | -2,379 | -3,812 | -1,195 | -2,512 | -2,589 |
其他收入及費用 | 84 | -145 | -1,286 | 80 | 1 | 7 | 34 | 63 | 79 | 106 |
利息費用 | 6 | 124 | 94 | 111 | 72 | - | - | - | - | - |
稅前純益 | -2,427 | -2,958 | -4,166 | -3,120 | -3,221 | -2,372 | -3,778 | -1,132 | -2,433 | -2,483 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -2,427 | -2,958 | -4,166 | -3,120 | -3,221 | -2,372 | -3,778 | -1,132 | -2,433 | -2,483 |
基本每股稅後盈餘(元) | -0.10 | -4.00 | - | -11.91 | -1.87 | -2.09 | - | -1.05 | -0.75 | -0.78 |
稀釋每股稅後盈餘(元) | 0.89 | -4.00 | -0.12 | -8.00 | -16.89 | -2.09 | -3.51 | -1.05 | -2.25 | -2.34 |
基本平均股數(千股) | 24542.00 | 739.00 | - | 262.00 | 1719.00 | 1133.00 | - | 1075.00 | 3227.00 | 3196.00 |
稀釋平均股數(千股) | 24542.00 | 739.00 | 2211.00 | 262.00 | 1719.00 | 1133.00 | 3239.00 | 1075.00 | 3227.00 | 3196.00 |
還原基本每股稅後盈餘(元) | -0.89 | -36.00 | - | -321.57 | -16.86 | -338.86 | - | -170.10 | -122.03 | -126.36 |
還原稀釋每股稅後盈餘(元) | 8.01 | -36.00 | -1.08 | -72.00 | -152.01 | -112.95 | -189.54 | -56.97 | -121.24 | -126.36 |
還原基本平均股數(千股) | 2,726 | 82 | - | 9 | 191 | 7 | - | 6 | 19 | 19 |
還原稀釋平均股數(千股) | 2,726 | 82 | 81 | 9 | 191 | 7 | 19 | 6 | 19 | 19 |
EBITDA(千元) | -2,400 | -2,747 | -4,001 | -2,926 | -3,095 | -2,372 | -3,778 | -1,132 | -2,433 | -2,483 |